Range
- - -
Vol / Avg.
-/1.2M
Div / Yield
-
52 Wk
23.3 - 46.85
Mkt Cap
3.6B
Payout Ratio
-
Open
-
P/E
-
EPS
-0.25
Shares
141.5M
Outstanding
141.5M
Total Float
86.6M
load more
Sector: Health Care.Industry: Biotechnology
Allogene Therapeutics Inc is a United States-based clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 which is developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS-0.460-0.250 0.2100
REV13.920M38.345M24.425M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ALLOAllogene Therapeutics0%3.6B

Allogene Therapeutics Frequently Asked Questions

Q

How do I buy Allogene Therapeutics (ALLO) stock?

A

You can purchase shares of Allogene Therapeutics (NASDAQ: ALLO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Allogene Therapeutics's (ALLO) competitors?

Q

What is the target price for Allogene Therapeutics (ALLO) stock?

A

The latest price target for Allogene Therapeutics (NASDAQ: ALLO) was reported by Truist Securities on May 20, 2021. The analyst firm set a price target for 41.00 expecting ALLO to rise to within 12 months (a possible 63.09% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Allogene Therapeutics (ALLO)?

A

The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $25.14 last updated Mon Jun 21 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Allogene Therapeutics (ALLO) pay a dividend?

A

There are no upcoming dividends for Allogene Therapeutics.

Q

When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?

A
Allogene Therapeutics’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Allogene Therapeutics (ALLO) going to split?

A

There is no upcoming split for Allogene Therapeutics.

Q

What sector and industry does Allogene Therapeutics (ALLO) operate in?

A

Allogene Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.